Unraveling germline predisposition in hematological neoplasms : Navigating complexity in the genomic era

Copyright © 2023 Elsevier Ltd. All rights reserved..

Genomic advancements have yielded pivotal insights into hematological neoplasms, particularly concerning germline predisposition mutations. Following the WHO 2016 revisions, dedicated segments were proposed to address these aspects. Current WHO 2022, ICC 2022, and ELN 2022 classifications recognize their significance, introducing more mutations and prompting integration into clinical practice. Approximately 5-10% of hematological neoplasm patients show germline predisposition gene mutations, rising with risk factors such as personal cancer history and familial antecedents, even in older adults. Nevertheless, technical challenges persist. Optimal DNA samples are skin fibroblast-extracted, although not universally applicable. Alternatives such as hair follicle use are explored. Moreover, the scrutiny of germline genomics mandates judicious test selection to ensure precise and accurate interpretation. Given the significant influence of genetic counseling on patient care and post-assessment procedures, there arises a demand for dedicated centers offering specialized services.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:64

Enthalten in:

Blood reviews - 64(2024) vom: 31. März, Seite 101143

Sprache:

Englisch

Beteiligte Personen:

Jerez, Joaquín [VerfasserIn]
Santiago, Marta [VerfasserIn]

Links:

Volltext

Themen:

Genetic counseling
Germline predisposition
Journal Article
Review
Technical challenges

Anmerkungen:

Date Completed 12.03.2024

Date Revised 12.03.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.blre.2023.101143

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM364809000